{
    "clinical_study": {
        "@rank": "79114", 
        "arm_group": [
            {
                "arm_group_label": "Resistant Starch Bagels", 
                "arm_group_type": "Active Comparator", 
                "description": "Bagels made from high-resistant starch flour (provides 24g resistant starch per day)"
            }, 
            {
                "arm_group_label": "Control Bagels", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Bagels made from wheat flour"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if consumption of bagels made with resistant\n      starch for 8 weeks can improve markers of type 2 diabetes, colon cancer and satiety in\n      adults."
        }, 
        "brief_title": "The Effect of Resistant Starch Bagels on Risk Factors of Type 2 Diabetes and Colorectal Cancer", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Colorectal Neoplasms", 
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "Using a randomized, double-blind crossover study design, we will determine the effect of\n      consuming bagels made with resistant starch daily for 8-weeks can reduce the risk of type 2\n      diabetes and colon cancer in an adults who are at an increased risk for type 2 diabetes.\n      Additionally, we will compare the satiating effect of these bagels to that of a standard\n      bagel."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males and postmenopausal females at least 40 year old\n\n          -  BMI \u226525 and <40 kg/m2\n\n          -  Waist circumference \u2265 102 cm for men, \u226588cm for women\n\n          -  CANRISK score \u226521 which indicates an elevated risk for type 2 diabetes\n\n        Exclusion Criteria:\n\n          -  Diabetes mellitus (fasting blood glucose \u2265 7.0 mmol/L)\n\n          -  Restrained eating habits\n\n          -  Gastrointestinal conditions (Celiac's disease, Crohn's disease, Ulcerative Colitis,\n             Inflammatory Bowel Disease)\n\n          -  Renal Conditions\n\n          -  Hepatic Conditions\n\n          -  Surgery or major medical event within 3 months of study start date\n\n          -  Select medication use (Glycemia medications, cholesterol-lowering agents, antibiotics\n             within 6 months of the study, other medications known to influence blood glucose\n             insulin, cholesterol, triglycerides, incretin hormones of the digestive tract\n             microbiome)\n\n          -  Select natural health product (NHP) use (Phytosterols or phytosterol functional\n             foods, other NHPs intended for glycemic or cholesterol control)\n\n          -  Gluten allergy or intolerance\n\n          -  Alcohol consumption >15 drinks/week for men and >10 drinks/week for women\n\n          -  Significant international travel within 6 months of the starting the study, or plans\n             to travel internationally during the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 29, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02129946", 
            "org_study_id": "13MY041"
        }, 
        "intervention": {
            "arm_group_label": "Resistant Starch Bagels", 
            "description": "In a randomized crossover fashion, participants will consume bagels that are made with either high-resistant starch or standard wheat flour, daily for a period of 8 weeks, with a 4 week washout period.", 
            "intervention_name": "Resistant Starch", 
            "intervention_type": "Other", 
            "other_name": "RS bagels"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Type 2 Diabetes", 
            "Resistant Starch", 
            "Postprandial Glucose", 
            "Postprandial Insulin", 
            "Satiety"
        ], 
        "lastchanged_date": "April 30, 2014", 
        "location": {
            "contact": {
                "last_name": "Alison M Duncan, Ph.D., R.D.", 
                "phone": "519-842-4120", 
                "phone_ext": "53416"
            }, 
            "facility": {
                "address": {
                    "city": "Guelph", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "N1G 2W1"
                }, 
                "name": "Human Nutraceutical Research Unit"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Human Clinical Trial to Investigate the Effects of Resistant Starch Bagels on Risk Factors of Type 2 Diabetes and Colorectal Cancer in Adults at Risk for Type 2 Diabetes", 
        "other_outcome": [
            {
                "description": "Questionnaires will be used to measure the participants' responses to the aroma, appearance, taste and texture of the study bagels.", 
                "measure": "Sensory response to study bagels", 
                "safety_issue": "No", 
                "time_frame": "Days 15, 29, 43 and 57 of both treatment periods"
            }, 
            {
                "description": "Questionnaires about bagel tolerance, including subjective ratings of tolerance and any adverse events will be completed every 2 weeks throughout both treatment periods (adverse events will be recorded as often as needed).", 
                "measure": "Resistant starch bagel tolerance", 
                "safety_issue": "No", 
                "time_frame": "Days 15, 29, 43 and 57 of both treatment periods"
            }, 
            {
                "description": "Body weight will be measures at every study visit.", 
                "measure": "Body weight", 
                "safety_issue": "No", 
                "time_frame": "Days 1, 15, 29, 43 and 57 of both treatment periods"
            }, 
            {
                "description": "Total-cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides will be measured from fasted blood samples on days 1 and 57 of both treatment periods.", 
                "measure": "Fasting serum lipids", 
                "safety_issue": "No", 
                "time_frame": "On days 1 and 57 of both treatment periods"
            }, 
            {
                "description": "Participants will complete 3-day food records a total of 3 times throughout the study to provide information about their background nutrient intake and dietary habits.", 
                "measure": "3-Day food records", 
                "safety_issue": "No", 
                "time_frame": "Over 3 days during the week before the study start date, and the week before study day 29 of both treatment periods."
            }
        ], 
        "overall_contact": {
            "email": "amduncan@uoguelph.ca", 
            "last_name": "Alison M Duncan, Ph.D., R.D.", 
            "phone": "519-824-4120", 
            "phone_ext": "53416"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Guelph, Human Nutraceutical Research Unit", 
                "last_name": "Alison M Duncan, Ph.D., R.D.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Guelph, Human Nutraceutical Research Unit", 
                "last_name": "Alison M Duncan, Ph.D., R.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Blood glucose will be measured in the fasting state and postprandially (during a 3-hour oral glucose tolerance test) on the first and last study days of both treatment periods.", 
                "measure": "Fasting and postprandial blood glucose", 
                "safety_issue": "No", 
                "time_frame": "up to day 57 of both treatment periods"
            }, 
            {
                "description": "Circulating insulin will be measured in the fasting state and postprandially (during a 3-hour oral glucose tolerance test) on the first and last study days of both treatment periods.", 
                "measure": "Fasting and postprandial insulin", 
                "safety_issue": "No", 
                "time_frame": "up to day 57 of both treatment periods"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02129946"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Guelph", 
            "investigator_full_name": "Alison Duncan", 
            "investigator_title": "Alison Duncan, Ph.D., R.D., Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "HbA1c (glycated haemoglobin) will be measured from fasting blood drawn on days 1 and 57 of both treatment periods.", 
                "measure": "HbA1c", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and 57 of both treatment periods"
            }, 
            {
                "description": "Data will be used from 3-hour oral glucose tolerance tests performed on days 1 and 57 of both treatment periods.", 
                "measure": "Calculated insulin sensitivity and beta-cell function", 
                "safety_issue": "No", 
                "time_frame": "Days 1 and 57 of both treatment periods"
            }, 
            {
                "description": "After study bagel consumption as part of a standard breakfast, questionnaires will be used to quantify subjective measures of satiety, and weighted food records will be used to objectively measure food intake for the rest of the day.", 
                "measure": "Satiety-producing effect", 
                "safety_issue": "No", 
                "time_frame": "Day 2,3 or 4 of both treatment periods"
            }
        ], 
        "source": "University of Guelph", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Ontario Ministry of Agriculture, Food and Rural Affairs", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Maple Leaf Foods, Canada Bread", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Guelph", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}